Abbott (ABT)
Makes glucose monitors, cardiovascular devices, diagnostic tests, nutrition products, and branded generic medicines.
$104.00
After hours+0.28 (+0.27%)
At close$103.72(+0.72%)
Something off on this page? Send us feedback.
Next report
Oct 21, 26
in 29 days
EPS estimate
$1.42
Revenue estimate
$12.99B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$1.34$1.09$1.26$1.30$1.50$1.15$1.31Pending
Estimate$1.34$1.07$1.26$1.30$1.50$1.14$1.28$1.42
Surprise0.0%+1.9%0.0%0.0%0.0%+0.9%+2.3%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$10.97B$10.36B$11.14B$11.37B$11.46B$11.16B$12.59BPending
Estimate$11.03B$10.41B$11.09B$11.39B$11.80B$11.00B$12.52B$12.99B
Surprise−0.5%−0.5%+0.5%−0.2%−2.9%+1.5%+0.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.89 | — | — |
| Sep 2028 | $1.74 | — | — |
| Jun 2028 | $1.62 | — | — |
| Mar 2028 | $1.45 | — | — |
| Dec 2027 | $1.75 | — | — |
| Sep 2027 | $1.58 | — | — |
| Jun 2027 | $1.45 | — | — |
| Mar 2027 | $1.29 | — | — |
| Dec 2026 | $1.63 | — | — |
| Oct 2026 | $1.42 | — | — |
| Jul 2026 | $1.28 | $1.31 | +2.3% |
| Apr 2026 | $1.14 | $1.15 | +0.9% |
| Jan 2026 | $1.50 | $1.50 | 0.0% |
| Oct 2025 | $1.30 | $1.30 | 0.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.89 | — | — | $15.59B | — | — | — |
| Sep 2028 | $1.74 | — | — | $14.96B | — | — | — |
| Jun 2028 | $1.62 | — | — | $14.50B | — | — | — |
| Mar 2028 | $1.45 | — | — | $13.68B | — | — | — |
| Dec 2027 | $1.75 | — | — | $14.52B | — | — | — |
| Sep 2027 | $1.58 | — | — | $13.92B | — | — | — |
| Jun 2027 | $1.45 | — | — | $13.50B | — | — | — |
| Mar 2027 | $1.29 | — | — | $12.81B | — | — | — |
| Dec 2026 | $1.63 | — | — | $13.55B | — | — | — |
| Oct 21, 2026 | $1.42 | — | — | $12.99B | — | — | — |
| Jul 16, 2026 | $1.28 | $1.31 | +2.3% | $12.52B | $12.59B | +0.6% | +10.7% |
| Apr 16, 2026 | $1.14 | $1.15 | +0.9% | $11.00B | $11.16B | +1.5% | −6.0% |
| Jan 22, 2026 | $1.50 | $1.50 | 0.0% | $11.80B | $11.46B | −2.9% | −10.0% |
| Oct 15, 2025 | $1.30 | $1.30 | 0.0% | $11.39B | $11.37B | −0.2% | −2.9% |
| Jul 17, 2025 | |||||||
| Apr 16, 2025 | |||||||
| Jan 22, 2025 | |||||||
| Oct 16, 2024 | |||||||
| Jul 18, 2024 | |||||||
| Apr 17, 2024 | |||||||
| Jan 24, 2024 | |||||||
| Oct 18, 2023 | |||||||
| Jul 20, 2023 | |||||||
| Apr 19, 2023 | |||||||
| Jan 25, 2023 | |||||||
| Oct 19, 2022 | |||||||
| Jul 20, 2022 | |||||||
| Apr 20, 2022 | |||||||
| Jan 26, 2022 | |||||||
| Oct 20, 2021 | |||||||
| Jul 22, 2021 | |||||||
| Apr 20, 2021 | |||||||
| Jan 27, 2021 | |||||||
| Oct 21, 2020 | |||||||
| Jul 16, 2020 | |||||||
| Apr 16, 2020 | |||||||
| Jan 22, 2020 | |||||||
| Oct 16, 2019 | |||||||
| Jul 17, 2019 | |||||||
| Apr 17, 2019 | |||||||
| Jan 23, 2019 | |||||||
| Oct 17, 2018 | |||||||
| Jul 18, 2018 | |||||||
| Apr 18, 2018 | |||||||
| Jan 24, 2018 | |||||||
| Oct 18, 2017 | |||||||
| Jul 20, 2017 | |||||||
| Apr 19, 2017 | |||||||
| Jan 25, 2017 | |||||||
| Oct 19, 2016 | |||||||
| Jul 20, 2016 | |||||||
| Apr 20, 2016 | |||||||
| Jan 28, 2016 | |||||||
| Oct 21, 2015 | |||||||
| Jul 22, 2015 |